My ePortfolio Register   

AACR 2014 /
New antibody-drug conjugate shows early promise against all forms of melanoma

5th - 9th Apr 2014

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 16.04.14
Views: 1744
Rating:

Dr Jeffrey Infante - Tennessee Oncology, Nashville, USA

At a press conference during AACR, Dr Jeffrey Infante discussed the DEDN6525A, which is a new member of a class of drugs called antibody-drug conjugates and shows evidence of activity against some forms of melanoma.

Read the article for more.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence